Rep. DeLauro Issues Statement on Ban Ranitidine Sales
January 11, 2020
January 11, 2020
WASHINGTON, Jan. 11 -- Rep. Rosa L. DeLauro, D-Connecticut, issued the following statement on Jan. 10:
At a news conference in the Capitol with medical experts, Congresswoman Rosa DeLauro (CT-03) reiterated her call to ban sales of ranitidine--the active ingredient in Zantac--and reintroduced the Recall Unsafe Drugs Act. Her legislation would give the United States Food and Drug Administration (FDA) mandatory recall authority over drugs and homeopathic products.
Joinin . . .
At a news conference in the Capitol with medical experts, Congresswoman Rosa DeLauro (CT-03) reiterated her call to ban sales of ranitidine--the active ingredient in Zantac--and reintroduced the Recall Unsafe Drugs Act. Her legislation would give the United States Food and Drug Administration (FDA) mandatory recall authority over drugs and homeopathic products.
Joinin . . .